Amphastar Pharmaceuticals Inc (AMPH)
40.92
+0.73
(+1.82%)
USD |
NASDAQ |
Apr 23, 16:00
40.92
0.00 (0.00%)
After-Hours: 17:36
Amphastar Pharmaceuticals Free Cash Flow (Quarterly): 14.42M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 14.42M |
September 30, 2023 | 54.14M |
June 30, 2023 | 45.87M |
March 31, 2023 | 30.90M |
December 31, 2022 | 8.916M |
September 30, 2022 | 14.75M |
June 30, 2022 | -3.147M |
March 31, 2022 | 44.63M |
December 31, 2021 | 33.56M |
September 30, 2021 | -4.65M |
June 30, 2021 | 26.42M |
March 31, 2021 | 15.21M |
December 31, 2020 | 7.564M |
September 30, 2020 | 3.176M |
June 30, 2020 | 19.20M |
March 31, 2020 | -6.529M |
December 31, 2019 | -2.758M |
September 30, 2019 | -20.68M |
June 30, 2019 | 42.15M |
March 31, 2019 | -18.50M |
December 31, 2018 | -0.065M |
September 30, 2018 | 3.146M |
Date | Value |
---|---|
June 30, 2018 | -7.718M |
March 31, 2018 | -3.98M |
December 31, 2017 | -0.353M |
September 30, 2017 | -8.941M |
June 30, 2017 | -1.727M |
March 31, 2017 | 15.13M |
December 31, 2016 | 8.669M |
September 30, 2016 | -5.403M |
June 30, 2016 | 3.928M |
March 31, 2016 | 9.984M |
December 31, 2015 | -0.782M |
September 30, 2015 | -0.759M |
June 30, 2015 | -0.937M |
March 31, 2015 | -2.837M |
December 31, 2014 | 3.497M |
September 30, 2014 | 9.411M |
June 30, 2014 | -2.294M |
March 31, 2014 | -10.06M |
December 31, 2013 | 4.656M |
September 30, 2013 | -3.834M |
June 30, 2013 | 16.85M |
March 31, 2013 | -4.932M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-20.68M
Minimum
Sep 2019
54.14M
Maximum
Sep 2023
17.01M
Average
14.75M
Median
Sep 2022
Free Cash Flow (Quarterly) Benchmarks
Eli Lilly and Co | -1.963B |
Dentsply Sirona Inc | 120.00M |
Pacira BioSciences Inc | 45.79M |
Organon & Co | 316.00M |
NovaBay Pharmaceuticals Inc | -0.316M |